Relevant bibliographies by topics / Intravenous Iron Transfusion

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers

Academic literature on the topic 'Intravenous Iron Transfusion'

Author: Grafiati
Published: 2 June 2025
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Intravenous Iron Transfusion.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Intravenous Iron Transfusion"

1

Etemady, Mike, Melika Hajizadeh, Beata Gidaszewski, Julie Ann Swain, Seng Chai Chua, and Marjan Khajehei. "Use of iron in perinatal anaemia: Indications for women’s health care policies and procedure." World Journal of Obstetrics and Gynecology 12, no. 4 (2023): 33–44. http://dx.doi.org/10.5317/wjog.v12.i4.33.

Full text
Abstract:
This paper reviews management of obstetric anaemia and the role of intravenous iron for the treatment of obstetric anaemia. Red blood cell transfusions are routinely used for haemoglobin restoration in anaemic women. The decision for red blood cell transfusion is made on a combination of haemoglobin level and clinical status, and it is suggested that transfusions are not necessary in those who are well compensated or when alternative therapy is available. To reduce the risk, intravenous iron infusion is proposed as a bloodless therapeutic approach. There are a variety of iron preparations. Int
APA, Harvard, Vancouver, ISO, and other styles
2

International, Journal of Medical Science and Innovative Research (IJMSIR). "Beyond Iron: Unmasking Hypophosphatemia in a Young Female Following Intravenous Iron Transfusion: A Case Report." International Journal of Medical Science and Innovative Research (IJMSIR) 9, no. 3 (2024): 01–03. https://doi.org/10.5281/zenodo.15403356.

Full text
Abstract:
<strong>Abstract</strong> Intravenous iron transfusions, commonly used to treat iron deficiency anaemia, are typically considered safe. However, this case report underscores a rare but noteworthy complication: Hypophosphatemia in a young woman after receiving this treatment. The case report details her clinical presentation, laboratory results, management, and outcome, highlighting the necessity for vigilance and proactive monitoring in similar situations.
APA, Harvard, Vancouver, ISO, and other styles
3

Stepin, A. V. "Supplement intravenous iron therapy in cardiac surgery." Russian journal of hematology and transfusiology 68, no. 2 (2023): 229–40. http://dx.doi.org/10.35754/0234-5730-2023-68-2-229-240.

Full text
Abstract:
Introduction. Preoperative anemia which is present in 25–40 % of cardiac surgery patients increases the risk of adverse postoperative outcomes leading to higher medical expenses. The tendency to restrict allogenic transfusion rate has led to the search for new pharmacological solutions to correct anemia in the perioperative period, nevertheless the usage of intravenous iron preparations in cardiac surgery is still not a generally accepted standard of treatment.Aim — review of the literature about the effects of perioperative intravenous iron therapy on the clinical outcomes in cardiac surgery.
APA, Harvard, Vancouver, ISO, and other styles
4

Engel, Jamie L., Joseph N. Gabra, Patrick Kane, and William J. Kurtz. "Intravenous Iron May Improve Outcomes in Elderly Patients With Operative Hip Fractures." Geriatric Orthopaedic Surgery & Rehabilitation 11 (January 1, 2020): 215145932091184. http://dx.doi.org/10.1177/2151459320911844.

Full text
Abstract:
Introduction: Hip fractures are common injuries with high morbidity and mortality rates. These patients often become anemic and require allogenic blood transfusion. Transfusions are costly with potential complications. This study examines the effect of intravenous (IV) iron on patients with hip fractures, undergoing surgery within 48 hours, and being treated with a highly restrictive transfusion protocol. Materials and Methods: A retrospective chart review performed on patients admitted to a level 1 tertiary care center with fractures of the proximal femur from December 2015 to December 2017 i
APA, Harvard, Vancouver, ISO, and other styles
5

MANIATIS, ALICE. "Intravenous iron as a transfusion alternative." Transfusion Alternatives in Transfusion Medicine 9, s2 Anemia Manag (2007): 13–18. http://dx.doi.org/10.1111/j.1778-428x.2007.00061.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Willmann, Patricia A., and Ashley Dean. "Retrospective Review of Total-Dose Iron Dextran in Iron-Deficiency Anemia of Chronic Disease and Relevance to Blood Transfusion Requirements: An Individual Institution Experience." Blood 112, no. 11 (2008): 2876. http://dx.doi.org/10.1182/blood.v112.11.2876.2876.

Full text
Abstract:
Abstract Background: Erythrocyte stimulating agents, iron replacement, and blood transfusions are options in the treatment of chronic anemia. Patients with iron deficiency anemia who cannot tolerate or unable to absorb oral iron may receive intravenous iron. Recent studies have been conducted proving the effectiveness of total-dose low molecular weight iron dextran for the treatment of chronic anemia. Low molecular weight iron dextran (Infed) is FDA approved for to treat iron-deficient anemia and is generally safe and effective. Low molecular weight iron dextran was chosen for this review due
APA, Harvard, Vancouver, ISO, and other styles
7

Barghi, Arvand, Robert Balshaw, Emily Rimmer, et al. "Red Blood Cell Transfusion and the Use of Intravenous Iron in Iron Deficient Patients Presenting to the Emergency Department." Blood 136, Supplement 1 (2020): 1–2. http://dx.doi.org/10.1182/blood-2020-141154.

Full text
Abstract:
Background: Red blood cell (RBC) transfusions are often used to treat patients with iron deficiency who present to the emergency department (ED) with symptomatic anemia. Intravenous (IV) iron is the preferred treatment in this setting, as it has been shown to increase hemoglobin concentration rapidly and durably. We aim to determine the incidence of iron deficiency anemia (IDA) and the management of these patients in the ED setting. Objectives: To evaluate the incidence of IDA, the frequency of RBC transfusion and iron supplementation, and factors associated with RBC transfusion. Study Design:
APA, Harvard, Vancouver, ISO, and other styles
8

Spradbrow, Jordan, Yulia Lin, Dominick Shelton, and Jeannie Callum. "Iron deficiency anemia in the emergency department: over-utilization of red blood cell transfusion and infrequent use of iron supplementation." CJEM 19, no. 3 (2016): 167–74. http://dx.doi.org/10.1017/cem.2016.388.

Full text
Abstract:
AbstractObjectivesThree are no clinical practice guidelines that specifically address the management of patients with iron deficiency anemia (IDA) in the emergency department (ED). The goal of this study was to describe the characteristics of IDA patients who present to the ED, documentation of IDA by emergency physicians, utilization of iron supplementation, and the appropriateness of red blood cell (RBC) transfusions ordered in the ED.MethodsA retrospective medical chart review was performed of IDA patients who visited the ED of a large tertiary center over a three-month period. Appropriaten
APA, Harvard, Vancouver, ISO, and other styles
9

Akshatha and R. L. N. Murthy. "Anaphylactic Reaction due to Ferric Carboxymaltose: A Case Report." Journal of Case Reports in Medical Science 11, no. 1 (2025): 1–6. https://doi.org/10.56557/jocrims/2024/v11i19248.

Full text
Abstract:
This case report describes a 24-year-old female patient admitted with severe iron deficiency anemia, presenting with generalized weakness, easy fatigability, and decreased appetite. The patient was initially treated with oral iron supplements, intravenous iron sucrose, and blood transfusion. However, the patient developed adverse reactions to both blood transfusions and iron sucrose. Subsequently, ferric carboxymaltose (FCM) was administered, but the patient experienced symptoms suggestive of an anaphylactic reaction, including hypotension, respiratory distress, and decreased oxygen saturation
APA, Harvard, Vancouver, ISO, and other styles
10

Richards, Toby, Ravishankar Rao Baikady, Ben Clevenger, et al. "Preoperative intravenous iron for anaemia in elective major open abdominal surgery: the PREVENTT RCT." Health Technology Assessment 25, no. 11 (2021): 1–58. http://dx.doi.org/10.3310/hta25110.

Full text
Abstract:
Background Anaemia affects 30–50% of patients before they undergo major surgery. Preoperative anaemia is associated with increased need for blood transfusion, postoperative complications and worse patient outcomes after surgery. International guidelines support the use of intravenous iron to correct anaemia in patients before surgery. However, the use of preoperative intravenous iron for patient benefit has not been assessed in the setting of a formal clinical trial. Objectives To assess if intravenous iron given to patients with anaemia before major abdominal surgery is beneficial by reducing
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Intravenous Iron Transfusion"

1

Froessler, Bernd. "Pre-operative anaemia management with intravenous iron: a systematic review." Thesis, 2013. http://hdl.handle.net/2440/82606.

Full text
Abstract:
BACKGROUND Iron deficiency anaemia (IDA) is a common condition in patients presenting for surgery and is found in up to 75% of non-cardiac surgical patients. Pre-operative haemoglobin (Hb) is a strong predictor of transfusion requirement and it should, as part of a comprehensive blood conservation approach, be optimised whenever possible. Treatment options for iron deficiency anaemia include oral and intravenous iron or red blood cell transfusion. That both, anaemia and red blood cell (RBC) transfusion expose the patient to unnecessary risks is supported by an ever-increasing body of evidence
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Intravenous Iron Transfusion"

1

Macdougall, Iain C. Clinical aspects and overview of renal anaemia. Edited by David J. Goldsmith. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199592548.003.0123.

Full text
Abstract:
Anaemia is an almost ubiquitous complication of chronic kidney disease, which has a number of implications for the patient. It is associated with adverse outcomes, an increased rate of red cell transfusions, poor quality of life, and reduced physical capacity. Severe anaemia also impacts on cardiac function, as well as on platelet function, the latter contributing to the bleeding diathesis of uraemia. Renal anaemia occurs mainly in the later stages of chronic kidney disease (stages 3B, 4, and 5), and up to 95% of patients on dialysis suffer from this condition. It is caused largely by inapprop
APA, Harvard, Vancouver, ISO, and other styles
2

Macdougall, Iain C. Erythropoiesis-stimulating agents in chronic kidney disease. Edited by David J. Goldsmith. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199592548.003.0124.

Full text
Abstract:
The advent of recombinant human erythropoietin (epoetin) in the late 1980s transformed the management of renal anaemia, liberating many dialysis patients from lifelong regular blood transfusions, in turn causing severe iron overload and human leucocyte antigen sensitization. Epoetin can be administered either intravenously or subcutaneously, but the half-life of the drug is fairly short at around 6–8 hours, necessitating frequent injections. To circumvent this problem, two manipulations to the erythropoietin molecule were engineered. The first of these was to attach an extra two carbohydrate c
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Intravenous Iron Transfusion"

1

Soni, Kapil Dev, and Rahul Chaurasia. "How to Use Blood and Blood Products." In Rational Use of Intravenous Fluids in Critically Ill Patients. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-42205-8_12.

Full text
Abstract:
AbstractThis chapter discusses the available evidence for blood transfusions in various subgroups of critically ill patients and other common issues pertaining to the transfusion of blood and blood components in the ICU. While blood and blood products can a be lifesaving therapy, the decision to transfuse should be based on individual factors, and the risk–benefit ratio of adverse events should be considered. Restrictive red blood cell (RBC) transfusion strategies are generally more beneficial, and platelet transfusions should be administered after risk assessment for bleeding, cause and patte
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Intravenous Iron Transfusion"

1

Mankodi, Sheena, Daniel Nissan, Voi Shim Wong, and Anthony Lerman. "PTU-115 Intravenous iron is effective in reducing the need for blood transfusion in acute medical settings." In British Society of Gastroenterology, Annual General Meeting, 4–7 June 2018, Abstracts. BMJ Publishing Group Ltd and British Society of Gastroenterology, 2018. http://dx.doi.org/10.1136/gutjnl-2018-bsgabstracts.493.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Umrani, Rohan, Hiral Amin, Ashley Pinckney, Charles Yang, and Daniel Tran. "Mixed Beri’s: High Output Heart Failure from Severe Anemia and Thiamine Deficiency." In 27th Annual Rowan-Virtua Research Day. Rowan University Libraries, 2023. https://doi.org/10.31986/issn.2689-0690_rdw.stratford_research_day.12_2023.

Full text
Abstract:
Background: Severe anemia and thiamine deficiency can independently result in high output heart failure (HOHF) through different mechanisms. Data on the threshold and timeframe at which these etiologies may precipitate HOHF is unclear. Case: A 63-year-old male with alcohol use disorder consuming 18 drinks/week presented with progressive shortness of breath and lower extremity edema for a few months. Physical exam revealed tachycardia, anasarca, jugular venous distension, Lancisi’s sign, and a midsystolic murmur. Echocardiogram demonstrated EF of 30-35%, dilated left ventricle, and cardiac inde
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Intravenous Iron Transfusion' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography